| 30/12/2022 |
Application for quotation of securities |
| 09/12/2022 |
Corporate Update and Acquisition |
| 29/11/2022 |
Amended Constitution |
| 29/11/2022 |
CEO’s AGM Address |
| 29/11/2022 |
Final Directors Interest Notice – Eck |
| 29/11/2022 |
Results of Annual General Meeting |
| 28/10/2022 |
Notice of Annual General Meeting/Proxy Form |
| 26/10/2022 |
Appendix 4C and Quarterly Activity Report |
| 17/10/2022 |
Director Resignation – Dennis Eck |
| 23/09/2022 |
Annual Report to Shareholders |
| 23/09/2022 |
Appendix 4G and Corporate Governance Statement |
| 16/09/2022 |
Change of Director’s Interest Notice – Greasley |
| 25/08/2022 |
Appendix 4E and FY22 Financial Report |
| 26/07/2022 |
Advangen Japan Divestment and Earn-Out Agreement |
| 26/07/2022 |
Appendix 4C and Quarterly Activity Report |
| 08/07/2022 |
Appointment of Exec Director, Corporate and Trading Update |
| 08/07/2022 |
Initial Director’s Interest Notice – Greasley |
| 28/04/2022 |
Appendix 4C and Quarterly Activity Report |
| 16/03/2022 |
New Leadership Driving Business Transformation |
| 02/03/2022 |
Notification of cessation of securities – AN1 |
| 01/03/2022 |
Anagenics Appoints CEO |
| 01/03/2022 |
Final Director’s Interest Notice – Halasz |
| 15/02/2022 |
Anagenics Board and Leadership Transition |
| 15/02/2022 |
Appendix 4D and Half Year Report |
| 15/02/2022 |
Final Director’s Interest Notice – Gordon |
| 15/02/2022 |
Initial Director’s Interest Notice – Beard |
| 02/02/2022 |
Change of Director’s Interest Notice – Halasz |
| 28/01/2022 |
Appendix 4C and Quarterly Activity Report |
| 20/01/2022 |
Change in substantial holding from HNG |
| 07/01/2022 |
Application for quotation of securities – AN1 |
| 07/01/2022 |
Change of Director’s Interest Notice – DE |
| 07/01/2022 |
Cleansing Notice |
| 07/01/2022 |
Release of Shares from Voluntary Escrow |
